Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868148 · ClinicalTrials.gov registry record
Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
A clinical trial of Rotator Cuff Tears and Osteoarthritis Shoulder, sponsored by Stryker Trauma and Extremities.
- Active
- Registry status
- 200
- Enrollment target
- 5
- Study locations
NCT05868148: Active study of Rotator Cuff Tears and Osteoarthritis Shoulder, sponsored by Stryker Trauma and Extremities.
NCT05868148 is a study of Rotator Cuff Tears and Osteoarthritis Shoulder that is active but no longer recruiting, run by Stryker Trauma and Extremities. The registered enrollment target is 200 participants, below the 1,271-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05868148, a study of Rotator Cuff Tears and Osteoarthritis Shoulder, is active but no longer recruiting, sponsored by Stryker Trauma and Extremities.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle and massive and non-repairable rotator cuff tear. The main questions it aims to answer are: * What is the average improvement in patient-reported shoulder function after 2 years when compared to before the surgery, and * What is the rate of surgical revisions needed over a 10 year period Patients will be asked to will be asked to regularly attend their check-up visits with their surgeon (including having x-rays or CT images taken to check their shoulder and implant), to complete questionnaires to report how their shoulder is doing, and to tell their surgeon when they notice any changes.
Primary Outcome
The average change in functional ability as measured by the American Shoulder and Elbow Surgeons (ASES) score. ASES is an absolute score ranging from 0 to 100 where a higher score indicates better shoulder function.
Conditions Studied
Interventions
- DEVICE Shoulder iD™ Primary Reversed Glenoid
Study Locations (5)
Texas
- UT Southwestern - Frisco
- UT Health Science center - Houston - Houston
California
- UCSF - San Francisco
Ohio
- Jameson Crane Sports Medicine Institute OSU - Columbus
Virginia
- Carilion Clinic - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-10-20 |
| Est. Completion | 2035-12 |
What the registry record for NCT05868148 still lists
NCT05868148 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,271-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (84% lower).
The record links to 7 conditions, with Rotator Cuff Tears appearing as the primary indexed condition, and to 1 intervention - of which Shoulder iD™ Primary Reversed Glenoid is the first listed.
NCT05868148 lists 5 locations in 4 states (Texas, California, Ohio).
Frequently Asked Questions
What is clinical trial NCT05868148 about?
NCT05868148 is a clinical study titled "Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study". The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in adult patients who have a functional deltoid muscle an...
What is the current status of trial NCT05868148?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2023-10-20. Estimated completion is 2035-12.
What conditions does trial NCT05868148 study?
This clinical trial studies the following conditions: Rotator Cuff Tears, Osteoarthritis Shoulder, Shoulder Deformity, Avascular Necrosis of the Head of Humerus, Rheumatoid Arthritis Shoulder.
What interventions are being tested in trial NCT05868148?
The interventions under investigation include: Shoulder iD™ Primary Reversed Glenoid (DEVICE).
Who is sponsoring clinical trial NCT05868148?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868148 being conducted?
This trial has 5 study locations across California, Ohio, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05868148's enrollment target sits among peer trials
200 5th of 20 higher than 16 of 20 other Rotator Cuff Tears trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
InSpace Accelerated Rehabilitation Study
RECRUITING · NA
-
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block
RECRUITING
-
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
RECRUITING · NA
-
Genetic Epidemiology of Rotator Cuff Tears: The cuffGEN Study
RECRUITING
-
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI